Skip to Content

Opdivo Prices, Coupons and Patient Assistance Programs

Opdivo (nivolumab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Colorectal Cancer, Esophageal Carcinoma, Head and Neck Cancer, and others.

Opdivo Prices

The cost for Opdivo intravenous solution (10 mg/mL) is around $1,172 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Opdivo price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Opdivo Coupons and Rebates

Opdivo offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Opdivo BMS Oncology Co-Pay Assistance Program: Eligible commercially insured patients may pay no more than $25 per infusion with savings of up to $25,000 per year; for additional information contact the program at 800-861-0048.

Applies to:
Opdivo
Number of uses:
12 times within calendar year
Expires
December 31, 2021

More information please phone: 800-861-0048 Visit Website

Opdivo/Yervoy (Regimen) BMS Oncology Co-Pay Assistance Program: Enrolled patients who have commercial insurance may pay no more than $25 per prescription with savings of up to $25,000 per year; for additional information contact the program at 800-861-0048.

Applies to:
Opdivo Yervoy Regimen
Number of uses:
12 times within calendar year
Expires
December 31, 2021

More information please phone: 800-861-0048 Visit Website

Patient Assistance Programs for Opdivo

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Opdivo (nivolumab) Injection; IV
  • Opdivo Yervoy Regimen (nivolumab and ipilimumab) Injection; IV infusion

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Opdivo (nivolumab) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: BMS Access Support (Oncology)

Elligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. Varies
  4. Must be residing in the US or Puerto Rico
  5. *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. This program also provides copay assistance.
Applicable drugs:
  • Opdivo (nivolumab) Injection; IV
  • Opdivo Yervoy Regimen (nivolumab and ipilimumab) Injection; IV infusion

More information please phone: 800-861-0048 Visit Website

Provider: Bristol Myers Squibb (BMS) Patient Support Program (Expanded: COVID-19)

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US.
  5. Eligibility determined on a case-by-case basis. Contact program for details: 1-800-721-8909
Applicable drugs:
  • Opdivo (nivolumab) Injection; IV
  • Opdivo Yervoy Regimen (nivolumab and ipilimumab) Injection; IV infusion

More information please phone: 800-721-8909 Visit Website